Fiasp 100 Unit (Insulin Aspart SOLUTION) 100 UNIT

FIASP 100 Unit insulin aspart solution is a fast-acting insulin used for managing blood glucose levels in diabetes. This subcutaneous injection, manufactured by Novo Nordisk Canada Inc., is designed for precise glucose control.

Strength

100 UNIT

Pack Size

1X10ML

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

FIASP insulin aspart is primarily used for the management of diabetes, helping to control blood sugar levels. It is often administered before meals to address rapid insulin needs. This fast-acting insulin is suitable for both type 1 and type 2 diabetes, aiding in the regulation of glucose levels throughout the day.

Side Effects

FIASP insulin aspart works quickly to lower blood sugar levels after meals. Users may experience improved glucose control, but individual responses can vary. Common effects include rapid onset and short duration of action, making it ideal for meal-time insulin needs.

Precautions & Warnings

FIASP insulin aspart should be handled with care, ensuring proper storage and administration. It is important to follow healthcare provider instructions for use. Monitor blood sugar levels regularly and be aware of potential hypoglycemia, especially when adjusting doses or changing insulin types.

Avoid Interactions

FIASP insulin aspart may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol and other substances that affect blood sugar levels should be used cautiously. Always consult a healthcare provider before combining FIASP with other treatments.

Frequently Asked Questions

FIASP insulin aspart is used for managing blood glucose levels in individuals with diabetes, typically administered before meals for rapid insulin action.

FIASP insulin aspart should be stored in a refrigerator between 2°C and 8°C. Once in use, it can be kept at room temperature for up to 4 weeks.

Common side effects may include hypoglycemia, injection site reactions, and allergic reactions. Individual responses can vary.

FIASP insulin aspart can be used in combination with other diabetes medications, but it is important to consult a healthcare provider to avoid potential interactions.

FIASP insulin aspart typically starts working within 5 to 10 minutes after injection, making it suitable for meal-time glucose control.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.